X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (1) 1
analysis (1) 1
antineoplastic agents - pharmacology (1) 1
biomarkers (1) 1
brca1 protein - genetics (1) 1
brca2 protein - genetics (1) 1
breast (1) 1
cancer (1) 1
carcinoma (1) 1
carcinoma, ovarian epithelial (1) 1
clinical trials (1) 1
deoxyribonucleic acid--dna (1) 1
dna methylation (1) 1
dna-repair (1) 1
drug resistance, neoplasm - drug effects (1) 1
fallopian tube neoplasms - drug therapy (1) 1
fallopian tube neoplasms - genetics (1) 1
fallopian tube neoplasms - pathology (1) 1
female (1) 1
follow-up studies (1) 1
genomic loss (1) 1
germ-line mutation - genetics (1) 1
hematology, oncology and palliative medicine (1) 1
heterozygosity (1) 1
homologous recombination deficiency (1) 1
humans (1) 1
index medicus (1) 1
indoles - therapeutic use (1) 1
international agencies (1) 1
middle aged (1) 1
monosaccharides (1) 1
mutant-cells (1) 1
mutation (1) 1
neoplasm recurrence, local - drug therapy (1) 1
neoplasm recurrence, local - genetics (1) 1
neoplasm recurrence, local - pathology (1) 1
neoplasm staging (1) 1
neoplasms, glandular and epithelial - drug therapy (1) 1
neoplasms, glandular and epithelial - genetics (1) 1
neoplasms, glandular and epithelial - pathology (1) 1
olaparib (1) 1
oncology (1) 1
ovarian cancer (1) 1
ovarian neoplasms - drug therapy (1) 1
ovarian neoplasms - genetics (1) 1
ovarian neoplasms - pathology (1) 1
peritoneal neoplasms - drug therapy (1) 1
peritoneal neoplasms - genetics (1) 1
peritoneal neoplasms - pathology (1) 1
platinum - pharmacology (1) 1
poly polymerase (1) 1
poly polymerase inhibitors - therapeutic use (1) 1
poly polymerases - chemistry (1) 1
prognosis (1) 1
prospective studies (1) 1
rodents (1) 1
salvage therapy (1) 1
sugars (1) 1
survival rate (1) 1
tumors (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 1, pp. 75 - 87
Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1... 
Hematology, Oncology and Palliative Medicine | POLY(ADP-RIBOSE) POLYMERASE | OLAPARIB | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTANT-CELLS | DNA-REPAIR | CANCER | HETEROZYGOSITY | TUMORS | BREAST | GENOMIC LOSS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.